-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 FUQzQ4hIC+eNqAxXQxtPaqjn11ehkA+8Ce0QjZ/I7jVTR6Jjfd3i0i4EXHs2Vo0g
 Fy4i/ZkxnD1eq8W05AwFNA==

<SEC-DOCUMENT>0000019617-01-000224.txt : 20010321
<SEC-HEADER>0000019617-01-000224.hdr.sgml : 20010321
ACCESSION NUMBER:		0000019617-01-000224
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20010320

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HANGER ORTHOPEDIC GROUP INC
		CENTRAL INDEX KEY:			0000722723
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
		IRS NUMBER:				840904275
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		
		SEC FILE NUMBER:	005-40189
		FILM NUMBER:		1572782

	BUSINESS ADDRESS:	
		STREET 1:		TWO BETHESDA METRO CENTER
		STREET 2:		SUITE 1300
		CITY:			BETHESDA
		STATE:			MD
		ZIP:			20814
		BUSINESS PHONE:		3019860701

	MAIL ADDRESS:	
		STREET 1:		TWO BETHESDA METRO CENTER
		STREET 2:		SUITE 1300
		CITY:			BETHESDA
		STATE:			MD
		ZIP:			20814

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SEQUEL CORP
		DATE OF NAME CHANGE:	19890814

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CELLTECH COMMUNICATIONS INC
		DATE OF NAME CHANGE:	19860304

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			J P MORGAN CHASE & CO
		CENTRAL INDEX KEY:			0000019617
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		IRS NUMBER:				132624428
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		270 PARK AVE
		STREET 2:		39TH FL
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		2122706000

	MAIL ADDRESS:	
		STREET 1:		270 PARK AVENUE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHASE MANHATTAN CORP /DE/
		DATE OF NAME CHANGE:	19960402

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEMICAL BANKING CORP
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEMICAL NEW YORK CORP
		DATE OF NAME CHANGE:	19880508
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<FILENAME>0001.txt
<TEXT>


                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                            -----------------------

                                SCHEDULE 13G/A
                                 (Rule 13d-102)

            INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
          TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED
                           PURSUANT TO RULE 13d-2(b)
                              (AMENDMENT  2 )

 				 HANGER ORTHOPEDIC GROUP, INC.
- --------------------------------------------------------------------------------
                              (Name of Issuer)

                                COMMON STOCK
- --------------------------------------------------------------------------------
                         (Title of Class of Securities)

                                 41043F208
- --------------------------------------------------------------------------------
                               (CUSIP Number)

                              DECEMBER 31, 2000
- --------------------------------------------------------------------------------
            (Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule
     is filed:
     |X| Rule 13d-1(b)
     | | Rule 13d-1(c)
     |_| Rule 13d-1(d)


<PAGE>


- -------------------                                            -----------------
CUSIP No.    41043F208             13G/A                    Page 1 of 5 Pages
- -------------------                                            -----------------

- --------------------------------------------------------------------------------
  1.  NAMES OF REPORTING PERSONS    J.P. Morgan Chase & Co.

      I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)  13-2624428
- --------------------------------------------------------------------------------
  2.  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                  (a) |_|
                                                                         (b) | |
- --------------------------------------------------------------------------------
  3.  SEC USE ONLY

- --------------------------------------------------------------------------------
  4.  CITIZENSHIP OR PLACE OF ORGANIZATION

      Delaware
- --------------------------------------------------------------------------------

      NUMBER OF           5.  SOLE VOTING POWER               0
        SHARES
     BENEFICIALLY         6.  SHARED VOTING POWER             0
       OWNED BY
         EACH             7.  SOLE DISPOSITIVE POWER          0
      REPORTING
     PERSON WITH          8.  SHARED DISPOSITIVE              0
                              POWER
- --------------------------------------------------------------------------------
  9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
		     0

- -------------------------------------------------------------------------------
 10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES  | |
      CERTAIN SHARES*

- --------------------------------------------------------------------------------
 11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

      0.0%

- --------------------------------------------------------------------------------
 12.    TYPE OF REPORTING PERSON*          HC

- --------------------------------------------------------------------------------


<PAGE>


Item 1(a).  Name of Issuer:

  	HANGER ORTHOPEDIC GROUP, INC.

Item 1(b).  Address of Issuer's Principal Executive Offices:

   	TWO BETHESDA METRO CENTER
	SUITE 1200
	BETHESDA MD  20814

Item 2(a).  Name of Person Filing:

     	J.P. MORGAN CHASE & CO

Item 2(b).  Address of Principal Business Office or, if None, Residence:

   	270 PARK AVE
	NEW YORK, NY 10017

Item 2(c).  Citizenship:

     Delaware

Item 2(d).  Title of Class of Securities:

     COMMON STOCK

     unless otherwise noted, security being reported is common stock

Item 2(e).  CUSIP Number:	41043F208


Item  3. If this Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b)
      or (c), Check Whether the Person Filing is a:

     (a) |_| Broker or dealer registered under Section 15 of the Exchange Act;

     (b) | | Bank as defined in Section 3(a)(6) of the Exchange Act;

     (c) |_| Insurance company as defined in Section 3(a)(19) of the
             Exchange Act;

     (d) |_| Investment company registered under Section 8 of the Investment
             Company Act;

     (e) |_| An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

     (f) |_| An employee benefit plan or endowment fund in accordance with
             Rule 13d-1(b)(1)(ii)(F);

     (g) |X| A parent holding company or control person in accordance with
             Rule 13d-1(b)(1)(ii)(G);

     (h) |_| A savings association as defined in Section 3(b) of the Federal
             Deposit Insurance Act;

     (i) |_| A church plan that is excluded from the definition of an investment
             company under Section 3(c)(14) of the Investment Company Act;

     (j) |_| Group, in accordance with Rule 13d-1(b)(1)(ii)(J).

If this statement is filed pursuant to Rule 13d-1(b), check this box. |X|


                               Page 2 of 5 Pages

<PAGE>


Item 4.   Ownership.

     Provide the following information regarding the aggregate number and
percentage of the class of securities of issuer identified in Item 1.

     (a)  Amount beneficially owned: 	0
		Including  0 shares where there is a Right to Acquire.

     (b)  Percent of class:     0.0%

     (c)  Number of shares as to which such person has:

           (i) Sole power to vote or to direct the vote:           0

          (ii) Shared power to vote or to direct the vote:         0

         (iii) Sole power to dispose or to direct the disposition of:          0

          (iv) Shared power to dispose or to direct the disposition of:        0

Item 5.   Ownership of Five Percent or Less of a Class.	Yes


     If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities, check the following. |_|

Item 6.   Ownership of More than Five Percent on Behalf of Another Person.
J.P. Morgan Chase & Co. is the beneficial owner of    0   shares of the
Issuer's common stock on behalf of other persons known to have one or more of
the following:
the right to receive dividends for such securities;
the power to direct the receipt of dividends from such securities;
the right to receive the proceeds from the sale of such securities;
the right to direct the receipt of proceeds from the sale of such securities;
No such person is known to have an interest in more than 5% of the class of
securities reported herein unless such person is identified below.



Item 7.   Identification and Classification of the Subsidiary Which Acquired the
          Security being reported on by the Parent Holding Company.

This notice is filed on behalf of J.P. Morgan Chase & Co. and its wholly owned
subsidiary, Robert Fleming, Inc.


Item 8.   Identification and Classification of Members of the Group.

     Not applicable

Item 9.   Notice of Dissolution of Group.

     Not applicable

Item 10.  Certifications.

     By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were not acquired and are not held for the
purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.


                               Page 3 of 5 Pages

<PAGE>


                                   SIGNATURE

     After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.


Dated: March 20, 2001                    J.P. Morgan Chase & Co.

                                       By: /s/ Margaret R. Rubin
                                          ------------------------------------
 							Margaret R. Rubin
                                          Vice President - Corporate Compliance





         The original statement shall be signed by each person on whose behalf
the statement is filed or his authorized representative. If the statement is
signed on behalf of a person by his authorized representative (other than an
executive officer or general partner of the filing person), evidence of the
representative's authority to sign on behalf of such person shall be filed with
the statement, provided, however, that a power of attorney for this purpose
which is already on file with the Commission may be incorporated by reference.
The name and any title of each person who signs the statement shall be typed or
printed beneath his signature.


                               Page 4 of 5 Pages

<PAGE>

                               Page 5 of 5 Pages

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
